Company Comparison
Syros Pharmaceuticals vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Syros Pharmaceuticals | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Syros Pharmaceuticals
Clinical-stage biotech developing cancer treatments by controlling gene expression using proprietary gene control platforms.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Syros Pharmaceuticals
Sector Overlap
Both Syros Pharmaceuticals and 54gene operate in Biotech.
Browse all Biotech companies →